5N Plus Inc. (VNP.TO)
Montreal, QC, CA
Headquartered in Montreal, Canada, 5N Plus Inc. is a global leader in the production and sale of semiconductors. Its operations span North America, Europe, and Asia, structured across two main segments: Specialty Semiconductors and Performance Materials. Within these divisions, 5N Plus manufactures and supplies a diverse array of advanced materials. This includes low melting point alloys, specialized semiconductor compounds and wafers, various chemicals, and raw metals. Additionally, it produces metallic powders crucial for micro-electronic and broader manufacturing sectors. The company further extends its offerings to include animal feed additives, pharmaceutical ingredients, and valuable recycling services. Its sophisticated materials and solutions cater to a wide spectrum of high-tech and essential industries. Key application areas encompass renewable energy, security, space exploration, pharmaceuticals, medical imaging, advanced manufacturing, electronics, consumer products, and general industrial uses.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.50% | +4.47% | +8.66% | +46.76% | +88.46% | +117.49% | +370.57% | +1,057.36% | +1,197.64% | +1,744.02% | +588.21% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+37.6% ★ Q1'26: +30.5% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+256.3% ★ Q1'26: +72.7% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+12.7% Q1'26: -20.7% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+18.9% ★ Q1'26: +24.0% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+19.8% ★ Q1'26: +24.2% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.3% Q1'26: +0.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.80× Q1'26: 1.16× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 3 EPS Ana. |
Dec 2027 6 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
183.07M
est: 446.61M (-59.0%)
|
551.68M
est: 558.39M (-1.2%)
|
459.01M
est: 461.03M (-0.4%)
|
508.20M
est: 531.33M (-4.4%)
|
311.01M
est: 322.52M (-3.6%)
|
231.50M
est: 230.33M (+0.5%)
|
219.92M
est: 215.65M (+2.0%)
|
218.00M
est: 227.80M (-4.3%)
|
195.97M
est: 194.34M (+0.8%)
|
177.19M
est: 170.18M (+4.1%)
|
209.99M
est: 201.12M (+4.4%)
|
264.22M
est: 272.06M (-2.9%)
|
242.37M
est: 195.73M (+23.8%)
|
289.28M
est: 292.31M (-1.0%)
|
397.91M
est: 380.36M (+4.6%)
|
456.27M
444.91M – 462.53M
+20.0% YoY
|
529.44M
507.89M – 550.80M
+16.0% YoY
|
| EBITDA |
37.01M
est: 64.95M (-43.0%)
|
-221.04M
est: 41.34M (-634.7%)
|
65.92M
est: 33.19M (+98.6%)
|
27.84M
est: 38.30M (-27.3%)
|
-53.37M
est: 20.24M (-363.7%)
|
14.17M
est: -47.05M (+130.1%)
|
27.08M
est: 803.2K (+3,272.1%)
|
29.18M
est: 15.08M (+93.6%)
|
19.05M
est: 14.36M (+32.6%)
|
22.60M
est: 9.32M (+142.6%)
|
25.24M
est: 10.03M (+151.7%)
|
5.17M
est: 9.50M (-45.6%)
|
43.88M
est: 28.46M (+54.1%)
|
49.82M
est: 42.51M (+17.2%)
|
93.15M
est: 55.31M (+68.4%)
|
66.35M
64.70M – 67.26M
+20.0% YoY
|
76.99M
73.86M – 80.10M
+16.0% YoY
|
| EBIT |
32.02M
est: 38.06M (-15.9%)
|
-243.24M
est: 20.87M (-1,265.4%)
|
53.22M
est: 16.75M (+217.6%)
|
28.30M
est: 19.33M (+46.4%)
|
-81.86M
est: 10.22M (-901.2%)
|
4.37M
est: -63.51M (+106.9%)
|
18.64M
est: 3.23M (+476.9%)
|
20.21M
est: 19.13M (+5.7%)
|
7.91M
est: 18.11M (-56.3%)
|
10.70M
est: 7.25M (+47.6%)
|
12.45M
est: 7.80M (+59.7%)
|
-12.82M
est: 7.39M (-273.5%)
|
27.51M
est: 16.68M (+64.9%)
|
32.78M
est: 24.91M (+31.6%)
|
75.01M
est: 32.41M (+131.4%)
|
38.88M
37.91M – 39.41M
+20.0% YoY
|
45.12M
43.28M – 46.94M
+16.0% YoY
|
| Net Income |
22.15M
est: 34.26M (-35.3%)
|
-227.74M
est: 13.52M (-1,784.7%)
|
42.66M
est: 10.85M (+293.1%)
|
10.81M
est: 12.52M (-13.7%)
|
-97.20M
est: 6.62M (-1,568.9%)
|
-5.90M
est: -70.16M (+91.6%)
|
12.02M
est: -5.56M (+316.3%)
|
13.97M
est: 12.34M (+13.2%)
|
1.79M
est: 12.38M (-85.6%)
|
2.19M
est: 1.57M (+39.0%)
|
3.11M
est: 1.69M (+83.8%)
|
-23.00M
est: -2.65M (-766.3%)
|
15.40M
est: 8.12M (+89.7%)
|
14.67M
est: 18.62M (-21.2%)
|
51.45M
est: 51.12M (+0.6%)
|
58.06M
56.30M – 59.82M
+13.6% YoY
|
74.97M
69.14M – 80.81M
+29.1% YoY
|
| SGA |
13.62M
est: 48.84M (-72.1%)
|
45.74M
est: 46.16M (-0.9%)
|
36.07M
est: 37.06M (-2.7%)
|
36.92M
est: 42.76M (-13.7%)
|
28.49M
est: 22.60M (+26.1%)
|
25.99M
est: 20.57M (+26.3%)
|
26.22M
est: 24.50M (+7.0%)
|
23.94M
est: 26.92M (-11.1%)
|
21.18M
est: 21.22M (-0.2%)
|
19.87M
est: 18.66M (+6.5%)
|
21.88M
est: 20.08M (+9.0%)
|
28.57M
est: 19.02M (+50.2%)
|
30.84M
est: 21.41M (+44.1%)
|
34.03M
est: 31.97M (+6.4%)
|
35.66M
est: 41.60M (-14.3%)
|
49.90M
48.66M – 50.58M
+20.0% YoY
|
57.90M
55.54M – 60.24M
+16.0% YoY
|
| EPS |
0.45
est: 0.38 (+18.2%)
|
-2.91
est: 0.14 (-2,228.4%)
|
0.51
est: 0.50 (+2.5%)
|
0.13
est: 0.12 (+4.1%)
|
-1.16
est: -0.19 (-498.4%)
|
-0.07
est: 0.05 (-241.5%)
|
0.14
est: 0.12 (+18.4%)
|
0.17
est: 0.18 (-5.8%)
|
0.02
est: 0.06 (-65.8%)
|
0.03
est: 0.09 (-65.8%)
|
0.04
est: 0.06 (-35.0%)
|
-0.28
est: -0.04 (-529.9%)
|
0.17
est: 0.09 (+85.8%)
|
0.17
est: 0.21 (-18.1%)
|
0.58
est: 0.57 (+1.8%)
|
0.65
0.63 – 0.66
+14.5% YoY
|
0.83
0.77 – 0.90
+27.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | B | 3/5 | 2/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | B | 3/5 | 2/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | B | 3/5 | 2/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-01 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-15 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Gervais Jacques | Chief Executive Officer & Director | 2M | male |
| Richard Perron | President & Chief Financial Officer | 1M | male |
| Roland Dubois | Chief Commercial Officer & Executive Vice President of Specialty Semiconductors | 866.3K | male |
| Paul Tancell | Executive Vice President of Performance Materials | 754.2K | male |
| Alban Fournier | Chief Financial Officer | 611.1K | male |
| William Alexander | Senior Director of Corporate Development & Innovation Management | 413.1K | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for VNP.TO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
